No Data
Sector Update: Health Care Stocks Rise in Friday Afternoon Trading
Express News | Revance Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 EPS Results and Raised Its FY24 Net Product Revenue Guidance Above Estimates
Revance Therapeutics Shares Jump After Q2 Loss Narrows, Revenue Rises
Express News | Piper Sandler Maintains Overweight on Revance Therapeutics, Lowers Price Target to $6
Revance Therapeutics Reports Surge in Aesthetic Portfolio Growth
Revance Therapeutics Is Maintained at Buy by Stifel